Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +15%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (495)

clinicaltrialsPublishedShowing 101–150 of 235 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02861898	Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma	recruiting	Phase 1 / Phase 2	33	Northwell HealthOTHER	1	Jun 1, 2026	clinicaltrials
NCT03213002	Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM(CAPTEM)	recruiting	Phase 1 / Phase 2	67	Northwell HealthOTHER	1	Jun 1, 2026	clinicaltrials